manufacturingchemist.com
21 articles from manufacturingchemist.com
Aenova Ups Topical Pharma Capacity to 50M Tubes/Year with Automated Line at FeldkirchenThis expansion signals the continuing consolidation of high-capacity topical pharma packaging in Europe, with serialization becoming a baseline requirement rath...
Samsung Bioepis Biosimilar OPUVIZ Enters European MarketThis launch demonstrates Samsung Bioepis executing a disciplined biosimilar pipeline strategy, with OPUVIZ completing the company's European ophthalmology portf...
Pfizer-Innovent $10.5B Deal Signals Strategic Pivot in ADC ManufacturingThis deal reflects how Chinese biotech has moved beyond cost arbitrage into genuine platform differentiation, particularly in ADC linkers and payloads. For manu...
Nestlé Health Science Licenses VOWST to IdB for European C. diff Prevention MarketThe VOWST licensing agreement represents a calculated expansion strategy for Nestlé Health Science, leveraging IdB's European regulatory expertise rather than p...
FDA Slams Dabur India OTC Plant With Nine Observations After Microbiological Falsification DiscoveryThis case demonstrates how data integrity failures cascade into equipment cleaning, quality oversight, and facility maintenance breakdowns • The systematic natu...
Guardware Targets Cleanroom Fit-Out Market with Tiered Stainless Steel Furniture RangeThe Guardware range targets mid-tier cleanroom operators who need 316L electropolished furniture with Ra ≤0.4µm surfaces but lack the budget for fully bespoke f...
ProBioGen's AGE1.CR.ReX Cell Line Targets Transgene Instability in Poxvirus ManufacturingThis platform addresses a fundamental manufacturing bottleneck in poxvirus vector development by separating selection pressure from expression phase, enabling f...
NorthStar and QSA Global Partner to Secure Rare Radium‑226 Supply Chain for Actinium‑225 ProductionBackground Targeted Alpha Therapies (TAT) depend on no‑carrier‑added (n.c.a.) Actinium‑225 (Ac‑225) as a potent alpha‑emitting radionuclide for oncology trials....
Pharmaceuticals Brace for ISO 42001 Audits as EU AI Act Deadline ApproachesPharmaceutical and chemical manufacturers face a narrow compliance window before the EU AI Act takes effect in August 2026 • ISO 42001 certification is becoming...
Ozone Layer Recovery Signals Manufacturing Reset as HFA Phaseout AcceleratesThe Montreal Protocol's track record demonstrates that regulatory intervention can drive atmospheric recovery, but the shift from CFCs to HFAs created a new com...
Almac's £500M Capital Programme Delivers Fifth Consecutive Year of Growth as CDMO Market TightensThis is a large-scale CDMO executing a capital-intensive growth strategy in a consolidating market. The financial metrics are solid, but engineers should focus ...
Single-Supplier Model Cuts Pharmaceutical Skid Integration Failures by 40% in Multi-Year TrialSingle-supplier integration models for pharmaceutical skids demonstrably reduce validation delays and commissioning overhead compared to fragmented multi-vendor...
Huber Unichillers Target Lab Cooling Efficiency with New Compact RangeThis product announcement addresses a real engineering problem: managing cooling loads efficiently across industrial and laboratory applications • Huber Unichil...
Karolinska Team Maps Rheumatoid Arthritis Pain Pathways Using Gene Therapy VectorsThis study demonstrates that targeted AAV delivery can resolve mechanistic questions in pain biology that broader approaches could not, specifically identifying...
Vetter Pharma Achieves Platinum Status in Best Managed Companies Recognition for Seventh Consecutive YearVetter's seventh consecutive Best Managed Companies award, enhanced to Platinum status, reflects sustained execution across strategy, operations, and workforce ...
Seqirus to Exit Penicillin Injection Market as Generics Reshape Australian Antibiotic Supply ChainSeqirus's exit from the Australian benzylpenicillin sodium market marks another example of commodity sterile injectables migrating away from major biopharma pla...
First Purpose-Built Tourette's Drug Halves Relapse Risk in Phase IIIThis is the first time a drug has been designed from the ground up for Tourette's syndrome, and the Phase 2 data shows it halves relapse risk compared to off-la...
FDA's New 483 Response Guidance Raises the Bar on Quality SystemThe FDA's March 2026 draft guidance makes the 15-day Form 483 response window a real deadline, not a suggestion. • Quality system documentation must now be com...
NSF Pharma Biotech Conference 2026: Why Compliance Alone Is No LongerThe NSF Pharma Biotech Conference 2026 makes clear that compliance is table stakes — the real differentiator is operational excellence. • Regulatory compliance ...
IMCD Taps Internal Talent for Middle East Expansion With YaghobiPromotion The Move IMCD Group has promoted Behnosh Yaghobi to Managing Director Middle East, a role she assumes on 1 June 2026. • Yaghobi joined IMCD in 2020 a...
Eli Lilly Drops Nearly $4bn on Three Vaccine Developers in MajorStrategic Pivot The Problem: A Portfolio Over-Indexed on Metabolic Disease Eli Lilly built its current market dominance on GLP-1 agonists. • Mounjaro and Zepbo...